Advertisement

Nutritional Intervention in Brain Aging

Reducing the effects of inflammation and oxidative stress
  • Francis C. Lau
  • Barbara Shukitt-Hale
  • James A. Joseph
Part of the Subcellular Biochemistry book series (SCBI, volume 42)

It is estimated that by the year 2050 the elderly (aged 65 or older) population will double the population of children (aged 0–14) for the first time in history. The expansion of the elderly population has already taken a toll on health care systems. In order to alleviate the health care costs and increase the quality of living in the aging population, it is crucial to explore methods that may retard or reverse the deleterious effects of aging. Inflammation and oxidative stress play important roles in brain aging. Inflammatory markers, as well as cellular and molecular oxidative damage, increase during normal brain aging. This increase is accompanied by the concomitant decline in cognitive and motor performance in the elderly population, even in the absence of neurodegenerative diseases. Epidemiological studies have shown that consumption of diets rich in antioxidant and anti-inflammatory agents, such as those found in fruits and vegetables, may lower the risk of developing age-related neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease. Research from our laboratory suggests that dietary supplementation with fruit or vegetable extracts can decrease the age-enhanced vulnerability to oxidative stress and inflammation. Additional research suggests that the polyphenolic compounds found in fruits such as blueberries may exert their beneficial effects through signal transduction and neuronal communication. Thus, nutritional intervention may exert therapeutic protection against age-related deficits and neurodegenerative diseases

Keywords

Oxidative Stress Nutritional Intervention Kainic Acid Neurobiol Aging Object Recognition Memory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr 2005; 81: 313S-316S.PubMedGoogle Scholar
  2. 2.
    Nicita-Mauro V. Parkinson’s disease, Parkinsonism and aging. Arch Gerontol Geriatr Suppl 2002; 35 Suppl:225–38.Google Scholar
  3. 3.
    Di Matteo V, Esposito E. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Curr Drug Targets CNS Neurol Disord 2003; 2:95–107.PubMedGoogle Scholar
  4. 4.
    Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported. Jama 1989; 262:2551–6.PubMedGoogle Scholar
  5. 5.
    Bickford PC, Shukitt-Hale B, Joseph J. Effects of aging on cerebellar noradrenergic function and motor learning: nutritional interventions. Mech Ageing Dev 1999; 111:141–54.PubMedGoogle Scholar
  6. 6.
    Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation. Journal of Neuroscience 1999; 19:8114–21.PubMedGoogle Scholar
  7. 7.
    Shukitt-Hale B, Smith DE, Meydani M, Joseph JA. The effects of dietary antioxidants on psychomotor performance in aged mice. Exp Gerontol 1999; 34:797–808.PubMedGoogle Scholar
  8. 8.
    Youdim KA, Shukitt-Hale B, MacKinnon S, Kalt W, Joseph JA. Polyphenolics enhance red blood cell resistance to oxidative stress: in vitro and in vivo. Biochim Biophys Acta 2000; 1523:117–22.PubMedGoogle Scholar
  9. 9.
    Galli RL, Shukitt-Hale B, Youdim KA, Joseph JA. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci 2002; 959:128–32.PubMedGoogle Scholar
  10. 10.
    Casadesus G, Shukitt-Hale B, Stellwagen HM, et al. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 2004; 7:309–16.PubMedGoogle Scholar
  11. 11.
    Goyarzu P, Malin DH, Lau FC, et al. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 2004; 7:75–83.PubMedGoogle Scholar
  12. 12.
    Joseph JA, Fisher DR, Carey AN. Fruit extracts antagonize Abeta- or DA-induced deficits in Ca2+ flux in M1-transfected COS-7 cells. J Alzheimers Dis 2004; 6:403–11; discussion 443–9.Google Scholar
  13. 13.
    Rice-Evans CA, Miller NJ. Antioxidant activities of flavonoids as bioactive components of food. Biochemical Society Transactions 1996; 24:790–794.PubMedGoogle Scholar
  14. 14.
    Bodles AM, Barger SW. Cytokines and the aging brain – what we don’t know might help us. Trends Neurosci 2004; 27:621–6.PubMedGoogle Scholar
  15. 15.
    Eikelenboom P, Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer’s disease. Neurobiol Aging 1996; 17:673–80.PubMedGoogle Scholar
  16. 16.
    O’Banion MK, Finch CE. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer’s disease. Neurobiol Aging 1996; 17:669–71.PubMedGoogle Scholar
  17. 17.
    Gordon MN, Schreier WA, Ou X, Holcomb LA, Morgan DG. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J Comp Neurol 1997; 388:106–19.PubMedGoogle Scholar
  18. 18.
    Rozovsky I, Finch CE, Morgan TE. Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging 1998; 19:97–103.PubMedGoogle Scholar
  19. 19.
    Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19:312–8.PubMedGoogle Scholar
  20. 20.
    Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson’s disease. Prog Neurobiol 2002; 68:325–40.PubMedGoogle Scholar
  21. 21.
    Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 1995; 369:131–5.PubMedGoogle Scholar
  22. 22.
    McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995; 21:195–218.PubMedGoogle Scholar
  23. 23.
    Chen S, Frederickson RC, Brunden KR. Neuroglial-mediated immunoinflammatory responses in Alzheimer’s disease: complement activation and therapeutic approaches. Neurobiol Aging 1996; 17:781–7.PubMedGoogle Scholar
  24. 24.
    Floyd RA. Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development. Free Radic Biol Med 1999; 26:1346–55.PubMedGoogle Scholar
  25. 25.
    Sheng JG, Mrak RE, Griffin WS. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl) 1998; 95:229–34.Google Scholar
  26. 26.
    Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol Aging 1999; 20:395–405.PubMedGoogle Scholar
  27. 27.
    Conde JR, Streit WJ. Microglia in the aging brain. J Neuropathol Exp Neurol 2006; 65:199–203.PubMedGoogle Scholar
  28. 28.
    Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer’s disease. Neurobiol Aging 2000; 21:383–421.PubMedGoogle Scholar
  29. 29.
    McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004; 1035:104–16.PubMedGoogle Scholar
  30. 30.
    Streit WJ. Microglia and Alzheimer’s disease pathogenesis. J Neurosci Res 2004; 77:1–8.PubMedGoogle Scholar
  31. 31.
    Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson’s disease. Annu Rev Neurosci 1999; 22:123–44.PubMedGoogle Scholar
  32. 32.
    Luterman JD, Haroutunian V, Yemul S, et al. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 2000; 57:1153–60.PubMedGoogle Scholar
  33. 33.
    Tarkowski E, Liljeroth AM, Minthon L, Tarkowski A, Wallin A, Blennow K. Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull 2003; 61:255–60.PubMedGoogle Scholar
  34. 34.
    Bauer J, Ganter U, Strauss S, et al. The participation of interleukin-6 in the pathogenesis of Alzheimer’s disease. Res Immunol 1992; 143:650–7.PubMedGoogle Scholar
  35. 35.
    Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer’s disease. Glia 1993; 7:75–83.PubMedGoogle Scholar
  36. 36.
    Rogers J, Webster S, Lue LF, et al. Inflammation and Alzheimer’s disease pathogenesis. Neurobiol Aging 1996; 17:681–6.PubMedGoogle Scholar
  37. 37.
    Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005; 26:349–54.PubMedGoogle Scholar
  38. 38.
    Goldgaber D, Harris HW, Hla T, et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A 1989; 86:7606–10.PubMedGoogle Scholar
  39. 39.
    Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 1995; 188:70–4.PubMedGoogle Scholar
  40. 40.
    Forloni G, Demicheli F, Giorgi S, Bendotti C, Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res Mol Brain Res 1992; 16:128–34.PubMedGoogle Scholar
  41. 41.
    Araujo DM, Cotman CW. Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer’s disease. Brain Res 1992; 569:141–5.PubMedGoogle Scholar
  42. 42.
    Gitter BD, Cox LM, Rydel RE, May PC. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc Natl Acad Sci U S A 1995; 92: 10738–41.PubMedGoogle Scholar
  43. 43.
    Tuppo EE, Arias HR. The role of inflammation in Alzheimer’s disease. Int J Biochem Cell Biol 2005; 37:289–305.PubMedGoogle Scholar
  44. 44.
    McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 1988; 38:1285–91.PubMedGoogle Scholar
  45. 45.
    Hirsch EC, Hunot S, Damier P, Faucheux B. Glial cells and inflammation in Parkinson’s disease: a role in neurodegeneration? Ann Neurol 1998; 44:S115–20.PubMedGoogle Scholar
  46. 46.
    Hirsch EC, Hunot S, Hartmann A. Neuroinflammatory processes in Parkinson’s disease. Parkinsonism Relat Disord 2005; 11 (1):S9-S15.PubMedGoogle Scholar
  47. 47.
    Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson’s disease. Neurosci Lett 1994; 172:151–4.PubMedGoogle Scholar
  48. 48.
    Durany N, Munch G, Michel T, Riederer P. Investigations on oxidative stress and therapeutical implications in dementia. Eur Arch Psychiatry Clin Neurosci 1999; 249 (3):68–73.PubMedGoogle Scholar
  49. 49.
    Floyd RA, Hensley K. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 2002; 23:795–807.PubMedGoogle Scholar
  50. 50.
    Grimble RF. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care 2003; 6:21–9.PubMedGoogle Scholar
  51. 51.
    Lane N. A unifying view of ageing and disease: the double-agent theory. J Theor Biol 2003; 225:531–40.PubMedGoogle Scholar
  52. 52.
    McGeer EG, McGeer PL. Inflammatory processes in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:741–9.PubMedGoogle Scholar
  53. 53.
    Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004; 58:39–46.PubMedGoogle Scholar
  54. 54.
    Halliwell B, Gutteridge JMC. Oxygen radicals and the nervous system. Trends in Neurosciences 1985; 8:22–26.Google Scholar
  55. 55.
    Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78:547–81.PubMedGoogle Scholar
  56. 56.
    Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:47–95.PubMedGoogle Scholar
  57. 57.
    Wickens AP. Ageing and the free radical theory. Respir Physiol 2001; 128:379–91.PubMedGoogle Scholar
  58. 58.
    Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47:412–26.PubMedGoogle Scholar
  59. 59.
    Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr 2005; 24:172–83.PubMedGoogle Scholar
  60. 60.
    Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273:59–63.PubMedGoogle Scholar
  61. 61.
    Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 1994; 91:10771–8.PubMedGoogle Scholar
  62. 62.
    Sastre J, Pallardo FV, Vina J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003; 35:1–8.PubMedGoogle Scholar
  63. 63.
    Nohl H, Gille L, Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol 2005; 69:719–23.PubMedGoogle Scholar
  64. 64.
    Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59:527–605.PubMedGoogle Scholar
  65. 65.
    Brewer GJ. Neuronal plasticity and stressor toxicity during aging. Exp Gerontol 2000; 35:1165–83.PubMedGoogle Scholar
  66. 66.
    Linton S, Davies MJ, Dean RT. Protein oxidation and ageing. Exp Gerontol 2001; 36:1503–18.PubMedGoogle Scholar
  67. 67.
    Balazy M, Nigam S. Aging, lipid modifications and phospholipases–new concepts. Ageing Res Rev 2003; 2:191–209.PubMedGoogle Scholar
  68. 68.
    Bokov A, Chaudhuri A, Richardson A. The role of oxidative damage and stress in aging. Mech Ageing Dev 2004; 125:811–26.PubMedGoogle Scholar
  69. 69.
    Junqueira VB, Barros SB, Chan SS, et al. Aging and oxidative stress. Mol Aspects Med 2004; 25:5–16.PubMedGoogle Scholar
  70. 70.
    Mecocci P, MacGarvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993; 34:609–16.PubMedGoogle Scholar
  71. 71.
    Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. 1991; 88:10540–10543.PubMedGoogle Scholar
  72. 72.
    Marcus DL, Thomas C, Rodriguez C, et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease. Exp Neurol 1998; 150:40–4.PubMedGoogle Scholar
  73. 73.
    Cavazzoni M, Barogi S, Baracca A, Parenti Castelli G, Lenaz G. The effect of aging and an oxidative stress on peroxide levels and the mitochondrial membrane potential in isolated rat hepatocytes. FEBS Lett 1999; 449:53–6.PubMedGoogle Scholar
  74. 74.
    Perez-Campo R, Lopez-Torres M, Cadenas S, Rojas C, Barja G. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J Comp Physiol [B] 1998; 168:149–58.Google Scholar
  75. 75.
    Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 1999; 39:67–101.PubMedGoogle Scholar
  76. 76.
    Davies KJ. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000; 50:279–89.PubMedGoogle Scholar
  77. 77.
    Annunziato L, Pannaccione A, Cataldi M, et al. Modulation of ion channels by reactive oxygen and nitrogen species: a pathophysiological role in brain aging? Neurobiol Aging 2002; 23:819–34.PubMedGoogle Scholar
  78. 78.
    Hughes KA, Reynolds RM. Evolutionary and Mechanistic Theories of Aging. Annu Rev Enzymol 2005; 50:421–425.Google Scholar
  79. 79.
    Waring P. Redox active calcium ion channels and cell death. Arch Biochem Biophys 2005; 434:33–42.PubMedGoogle Scholar
  80. 80.
    Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18:685–716.PubMedGoogle Scholar
  81. 81.
    Rego AC, Oliveira CR. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 2003; 28:1563–74.PubMedGoogle Scholar
  82. 82.
    Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 1995; 45:1594–601.PubMedGoogle Scholar
  83. 83.
    Dexter DT, Holley AE, Flitter WD, et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord 1994; 9:92–7.PubMedGoogle Scholar
  84. 84.
    Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 1998; 71:2112–22.PubMedGoogle Scholar
  85. 85.
    Munch G, Schinzel R, Loske C, et al. Alzheimer’s disease–synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 1998; 105:439–61.PubMedGoogle Scholar
  86. 86.
    Marklund SL, Westman NG, Lundgren E, Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 1982; 42:1955–61.PubMedGoogle Scholar
  87. 87.
    Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609–23.PubMedGoogle Scholar
  88. 88.
    Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222:236–45.PubMedGoogle Scholar
  89. 89.
    Joseph JA, Denisova N, Fisher D, Bickford P, Prior R, Cao G. Age-related neurodegeneration and oxidative stress: putative nutritional intervention. Neurol Clin 1998; 16:747–55.PubMedGoogle Scholar
  90. 90.
    Joseph JA, Denisova N, Fisher D, et al. Membrane and receptor modifications of oxidative stress vulnerability in aging. Nutritional considerations. Ann N Y Acad Sci 1998; 854:268–76.Google Scholar
  91. 91.
    Bartus RT. Drugs to treat age-related neurodegenerative problems. The final frontier of medical science? J. Am. Geriat. Soc. 1990; 38:680–695.PubMedGoogle Scholar
  92. 92.
    Joseph JA, Bartus RT, Clody D, et al. Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation. Neurobiol Aging 1983; 4:313–9.PubMedGoogle Scholar
  93. 93.
    Kluger A, Gianutsos JG, Golomb J, et al. Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer’s disease. J. Gerontol. 1997; 52:28–39.Google Scholar
  94. 94.
    Shukitt-Hale B. The effects of aging and oxidative stress on psychomotor and cognitive behavior. Age 1999; 22:9–17.Google Scholar
  95. 95.
    Hauss-Wegrzyniak B, Vannucchi MG, Wenk GL. Behavioral and ultrastructural changes induced by chronic neuroinflammation in young rats. Brain Res 2000; 859:157–66.PubMedGoogle Scholar
  96. 96.
    Hauss-Wegrzyniak B, Vraniak P, Wenk GL. The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiol Aging 1999; 20:305–13.PubMedGoogle Scholar
  97. 97.
    Ingram DK, Jucker M, Spangler EL. Behavioral manifestations of aging. 1994; 2:149–170.Google Scholar
  98. 98.
    Muir JL. Acetylcholine, aging, and Alzheimer’s disease. Pharmacol. Biochem. Behav. 1997; 56:687–696.PubMedGoogle Scholar
  99. 99.
    Shukitt-Hale B, Mouzakis G, Joseph JA. Psychomotor and spatial memory performance in aging male Fischer 344 rats. Exp. Gerontol. 1998; 33:615–624.PubMedGoogle Scholar
  100. 100.
    West RL. An application of pre-frontal cortex function theory to cognitive aging. Psych. Bull. 1996; 120:272–292.Google Scholar
  101. 101.
    Devan BD, Goad EH, Petri HL. Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze. Neurobiol. Learn. Mem. 1996; 66:305–323.PubMedGoogle Scholar
  102. 102.
    McDonald RJ, White NM. Parallel information processing in the water maze: Evidence for independent memory systems involving dorsal striatum and hippocampus. Behav. Neural Biol. 1994; 61:260–270.PubMedGoogle Scholar
  103. 103.
    Oliveira MGM, Bueno OFA, Pomarico AC, Gugliano EB. Strategies used by hippocampal- and caudate-putamen-lesioned rats in a learning task. Neurobiol. Learn. Mem. 1997; 68:32–41.PubMedGoogle Scholar
  104. 104.
    Zyzak DR, Otto T, Eichenbaum H MG. Cognitive Decline Associated with Normal Aging in Rats: A Neuropsychological Approach. Learning and Memory 1995; 2:1–16.PubMedGoogle Scholar
  105. 105.
    Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci U S A 1996; 93:4765–9.PubMedGoogle Scholar
  106. 106.
    Joseph JA. The putative role of free radicals in the loss of neuronal functioning in senescence. Integ. Physiol. Behav. Sci. 1992; 27:216–227.Google Scholar
  107. 107.
    Bickford P, Heron C, Young DA, Gerhardt GA, De La Garza R. Impaired acquisition of novel locomotor tasks in aged and norepinephrine-depleted F344 rats. Neurobiol Aging 1992; 13:475–81.PubMedGoogle Scholar
  108. 108.
    Bickford P. Motor learning deficits in aged rats are correlated with loss of cerebellar noradrenergic function. Brain Res 1993; 620:133–8.PubMedGoogle Scholar
  109. 109.
    Joseph JA, Erat S, Rabin BM. CNS effects of heavy particle irradiation in space: behavioral implications. Adv. Space Res. 1998; 22:209–216.PubMedGoogle Scholar
  110. 110.
    Joseph JA, Shukitt-Hale B, McEwen J, Rabin BM. CNS-induced deficits of heavy particle irradiation in space: the aging connection. Adv Space Res 2000; 25:2057–64.PubMedGoogle Scholar
  111. 111.
    Shukitt-Hale B, Casadesus G, McEwen JJ, Rabin BM, Joseph JA. Spatial learning and memory deficits induced by exposure to iron-56-particle radiation. Radiat Res 2000; 154:28–33.PubMedGoogle Scholar
  112. 112.
    Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease. Brain Res 1998; 780:294–303.PubMedGoogle Scholar
  113. 113.
    Hauss-Wegrzyniak B, Willard LB, Del Soldato P, Pepeu G, Wenk GL. Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res 1999; 815:36–43.PubMedGoogle Scholar
  114. 114.
    Yamada K, Komori Y, Tanaka T, et al. Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience 1999; 88:281–94.PubMedGoogle Scholar
  115. 115.
    Cui K, Luo X, Xu K, Ven Murthy MR. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:771–99.PubMedGoogle Scholar
  116. 116.
    Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 2004; 96:229–45.PubMedGoogle Scholar
  117. 117.
    Joseph JA, Fisher DR, Bielinski D. Blueberry extract alters oxidative stress-mediated signaling in COS-7 cells transfected with selectively vulnerable muscarinic receptor subtypes. J Alzheimer’s Dis 2005; 9.Google Scholar
  118. 118.
    Vaya J, Aviram M. Nutritional Antioxidants: Mechanisms of Action, Analyses of Activities and Medical Applications. Curr Med Chem – Imm, Endoc & Metab Agents 2001; 1:99–117.Google Scholar
  119. 119.
    Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. Dietary flavonoids as potential neuroprotectants. Biol Chem 2002; 383:503–19.PubMedGoogle Scholar
  120. 120.
    Youdim KA, Joseph JA. Phytochemicals and brain aging: a mutiplicity of effects. In: Rice-Evans C, Packer L, eds. Flavonoids in health and disease. New York: Marcel Dekker, Inc., 2003; 205–231.Google Scholar
  121. 121.
    Deschamps V, Barberger-Gateau P, Peuchant E, Orgogozo JM. Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology 2001; 20:7–15.PubMedGoogle Scholar
  122. 122.
    Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. Jama 2002; 287:3223–9.PubMedGoogle Scholar
  123. 123.
    Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm 2003; 110:95–110.PubMedGoogle Scholar
  124. 124.
    Hu HL, Forsey RJ, Blades TJ, Barratt ME, Parmar P, Powell JR. Antioxidants may contribute in the fight against ageing: an in vitro model. Mech Ageing Dev 2000; 121:217–30.PubMedGoogle Scholar
  125. 125.
    Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem 2001; 1:569–90.PubMedGoogle Scholar
  126. 126.
    Turnbull JJ, Nakajima J, Welford RW, Yamazaki M, Saito K, Schofield CJ. Mechanistic studies on three 2-oxoglutarate-dependent oxygenases of flavonoid biosynthesis: anthocyanidin synthase, flavonol synthase, and flavanone 3beta-hydroxylase. J Biol Chem 2004; 279:1206–16.PubMedGoogle Scholar
  127. 127.
    Bagchi D, Sen CK, Bagchi M, Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc) 2004; 69:75–80, 1 p preceding 75.Google Scholar
  128. 128.
    Kong JM, Chia LS, Goh NK, Chia TF, Brouillard R. Analysis and biological activities of anthocyanins. Phytochemistry 2003; 64:923–33.PubMedGoogle Scholar
  129. 129.
    Francis FJ. Food colorants: Anthocyanins. Crit. Rev. Food Sci. Nutr. 1989; 28:273–314.PubMedGoogle Scholar
  130. 130.
    Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 2002; 50:7731–7.PubMedGoogle Scholar
  131. 131.
    Wang H, Cao G, Prior RL. Total antioxidant capacity of fruits. J Agric Food Chem 1996; 44:701–705.Google Scholar
  132. 132.
    Prior RL, Cao G, Martin A, et al. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity and variety of Vaccinium species. J Agric Food Chem 1998; 46:2586–2593.Google Scholar
  133. 133.
    Kalt W, Ryan DA, Duy JC, Prior RL, Ehlenfeldt MK, Vander Kloet SP. Interspecific variation in anthocyanins, phenolics, and antioxidant capacity among genotypes of highbush and lowbush blueberries (Vaccinium section cyanococcus spp.). J Agric Food Chem 2001; 49:4761–7.PubMedGoogle Scholar
  134. 134.
    Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem 2004; 52:4026–37.PubMedGoogle Scholar
  135. 135.
    Youdim KA, Shukitt-Hale B, Joseph JA. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004; 37:1683–93.PubMedGoogle Scholar
  136. 136.
    Andres-Lacueva C, Shukitt-Hale B, Galli RL, Jauregui O, Lamuela-Raventos RM, Joseph JA. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 2005; 8:111–20.PubMedGoogle Scholar
  137. 137.
    Youdim KA, Shukitt-Hale B, Martin A, Wang H, Denisova N, Joseph JA. Short-term dietary supplementation of blueberry polyphenolics: beneficial effects on aging brain performance and peripheral tissue function. Nutritional Neuroscience 2000; 3:383–97.Google Scholar
  138. 138.
    Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004; 36:838–49.PubMedGoogle Scholar
  139. 139.
    Landfield PW, Eldridge JC. The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium. Ann N Y Acad Sci 1994; 746:308–21; discussion 321–6.Google Scholar
  140. 140.
    Jaffee E, Hoyer L, Nachman R. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc. Natl. Acad. Sci. USA 1974; 71:1906–1913.Google Scholar
  141. 141.
    Egashira T, Takayama F, Yamanaka Y. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries. Jap. J. Pharmacol. 1996; 72:57–65.PubMedGoogle Scholar
  142. 142.
    Joseph JA, Roth GS, Strong R. The striatum, A microcosm for the examination of age-related alterations in the CNS: A selected review. Rev. Biologic. Res. 1990; 4:181–199.Google Scholar
  143. 143.
    Kornhuber J, Schoppmeyer K, Bendig C, Riederer P. Characterization of [3H] pentazocine binding sites in post-mortem human frontal cortex. J. Neural. Trans. 1996; 103:45–53.Google Scholar
  144. 144.
    Joseph JA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 2003; 6:153–62.PubMedGoogle Scholar
  145. 145.
    Micheau J, Riedel G. Protein kinases: which one is the memory molecule? Cell Mol Life Sci 1999; 55:534–48.PubMedGoogle Scholar
  146. 146.
    Bickford PC, Gould T, Briederick L, et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 2000; 866:211–217.PubMedGoogle Scholar
  147. 147.
    Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16:2027–33.PubMedGoogle Scholar
  148. 148.
    Gage FH, Kempermann G, Palmer TD, Peterson DA, Ray J. Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol 1998; 36:249–66.PubMedGoogle Scholar
  149. 149.
    Drapeau E, Mayo W, Aurousseau C, Le Moal M, Piazza PV, Abrous DN. Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc Natl Acad Sci U S A 2003; 100:14385–90.PubMedGoogle Scholar
  150. 150.
    Shukitt-Hale B, Carey A, Simon LE, et al. Fruit polyphenols prevent inflammatory mediated decrements in cognition. Soc. Neurosci. Abs. 2004; 30:565.5.Google Scholar
  151. 151.
    Lau FC, Shukitt-Hale B, Joseph JA. Effect of blueberry supplementation on gene expression in the hippocampus of kainic acid-treated and control rats. Soc. Neurosci. Abs. 2004; 30:565.6.Google Scholar
  152. 152.
    Sweeney MI, Kalt W, MacKinnon SL, Ashby J, Gottschall-Pass KT. Feeding rats diets enriched in lowbush blueberries for six weeks decreases ischemia-induced brain damage. Nutr Neurosci 2002; 5:427–31.PubMedGoogle Scholar
  153. 153.
    Stromberg I, Gemma C, Vila J, Bickford PC. Blueberry- and spirulina-enriched diets enhance striatal dopamine recovery and induce a rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system. Exp Neurol 2005; 196:298–307.PubMedGoogle Scholar
  154. 154.
    Roth GS, Joseph JA, Mason RP. Membrane alterations as causes of impaired signal transduction in Alzheimer’s disease and aging. Trends Neurosci 1995; 18:203–6.PubMedGoogle Scholar
  155. 155.
    Fowler CJ, Cowburn RF, Joseph JA. Alzheimer’s, ageing and amyloid: an absurd allegory? Gerontology 1997; 43:132–42.PubMedGoogle Scholar
  156. 156.
    Joseph JA, Villalobos-Molina R, Yamagami K, Roth GS, Kelly J. Age-specific alterations in muscarinic stimulation of K(+)-evoked dopamine release from striatal slices by cholesterol and S-adenosyl-L-methionine. Brain Res 1995; 673:185–93.PubMedGoogle Scholar
  157. 157.
    Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog Neurobiol 1998; 56:541–69.PubMedGoogle Scholar
  158. 158.
    Elhusseiny A, Cohen Z, Olivier A, Stanimirovic DB, Hamel E. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab 1999; 19:794–802.PubMedGoogle Scholar
  159. 159.
    Joseph JA, Fisher DR, Carey A, Szprengiel A. The M3 muscarinic receptor i3 domain confers oxidative stress protection on calcium regulation in transfected COS-7 cells. Aging Cell 2004; 3:263–71.PubMedGoogle Scholar
  160. 160.
    Yi W, Fischer J, Krewer G, Akoh CC. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem 2005; 53:7320–9.PubMedGoogle Scholar
  161. 161.
    Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 2001; 10:383–92, x.PubMedGoogle Scholar
  162. 162.
    Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RA. Blueberry flavonoids inhibit matrix metalloproteinase activity in DU145 human prostate cancer cells. Biochem Cell Biol 2005; 83:637–43.PubMedGoogle Scholar
  163. 163.
    Lau FC, Bielinski DF, Joseph JA. Inhibitory effect of blueberry extract on the production of inflammatory mediators in LPS-activated BV2 microglia. Age 2006; 28:46.Google Scholar
  164. 164.
    Wilson MA, Shukitt-Hale B, Kalt W, Ingram DK, Joseph JA, Wolkow CA. Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 2006; 5:59–68.PubMedGoogle Scholar
  165. 165.
    Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Ann. Rev. Pharmacol. Toxicol 1996; 36:83–106.Google Scholar
  166. 166.
    Hughes DA. Dietary antioxidants and human immune function. Nutrition Bulletin 2000; 25:35–41.Google Scholar
  167. 167.
    Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003; 111:163–9.PubMedGoogle Scholar
  168. 168.
    McGeer PL, McGeer EG. Inflammation and neurodegeneration in Parkinson’s disease. Parkinsonism Relat Disord 2004; 10 ( 1): S3–7.PubMedGoogle Scholar
  169. 169.
    Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 2002; 23:719–35.PubMedGoogle Scholar
  170. 170.
    Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004; 65: 995–1016.PubMedGoogle Scholar
  171. 171.
    Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004; 44:275–95.PubMedGoogle Scholar
  172. 172.
    Cao G, Sofic E, Prior RL. Antioxidant capacity of tea and common vegetables. J. Agric. Food Chem. 1996; 44:3426–3431.Google Scholar
  173. 173.
    Prior RL, Cao G. Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J AOAC Int 2000; 83:950–6.PubMedGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Francis C. Lau
    • 1
  • Barbara Shukitt-Hale
    • 1
  • James A. Joseph
    • 1
  1. 1.USDA-ARSHuman Nutrition Research Center on Aging at Tufts UniversityBostonUSA

Personalised recommendations